MedTrace Logo

Simvastatin Treatment of Patients With Acute Optic Neuritis

NCT00261326 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2011-01-10

No results posted yet for this study

Summary

The purpose of this study is to investigate if the simvastatin treatment improve the visual function after 3 months of the inclusion to this project and if the simvastatin influences the results on cerebral MRI after 3 and 6 months of the inclusion. In addition the development of new demyelinating relapses. In the patients with monosymptomatic acut optic neuritis to investigate whether the simvastatin reduces the risk to develop multiple sclerosis (MS).

Conditions

Interventions

DRUG

simvastatin

80 mg once daily

DRUG

placebo

calcium tablets once daily

Sponsors & Collaborators

  • Alpharma ApS

    collaborator INDUSTRY

  • Glostrup University Hospital, Copenhagen

    lead OTHER

Principal Investigators

  • Jette L Frederiksen, Dr.Med

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
59 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-09-30
Primary Completion
2010-01-31
Completion
2011-05-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00261326 on ClinicalTrials.gov